Charles Rhyee
Stock Analyst at TD Cowen
(1.42)
# 2,854
Out of 4,412 analysts
36
Total ratings
34.78%
Success rate
-9.56%
Average return
Main Sectors:
18 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Hold | $16 → $15 | $13.01 | +15.30% | 4 | Apr 26, 2024 | |
| ICLR ICON PLC | Maintains: Buy | $343 → $349 | $308.31 | +13.20% | 1 | Apr 26, 2024 | |
| GDRX GoodRx Holdings | Maintains: Outperform | $12 → $14 | $7.19 | +94.71% | 6 | Mar 1, 2024 | |
| CRL Charles River Laboratories International | Maintains: Market Perform | $212 → $209 | $229.03 | -8.75% | 2 | Sep 25, 2023 | |
| CAH Cardinal Health | Maintains: Market Perform | $88 → $90 | $103.21 | -12.80% | 1 | Aug 16, 2023 | |
| TALK Talkspace | Maintains: Outperform | $4 → $5 | $3.12 | +60.26% | 2 | May 3, 2023 | |
| AMWL American Well | Downgrades: Market Perform | $5 → $2.5 | $0.53 | +373.48% | 3 | Mar 23, 2023 | |
| VEEV Veeva Systems | Maintains: Market Perform | $184 → $189 | $200.91 | -5.93% | 2 | Mar 6, 2023 | |
| IQV IQVIA Holdings | Initiates: Outperform | $251 | $234.88 | +6.86% | 1 | Dec 6, 2022 | |
| HLTH Cue Health | Maintains: Outperform | $9 → $7 | $0.14 | +4,864.54% | 2 | Nov 14, 2022 | |
| OWLT Owlet | Maintains: Outperform | $70 → $56 | $4.16 | +1,246.15% | 2 | Oct 20, 2022 | |
| DRIO DarioHealth | Maintains: Outperform | $18 → $14 | $1.48 | +845.95% | 3 | Aug 16, 2022 | |
| EVH Evolent Health | Maintains: Outperform | $48 → $50 | $27.65 | +80.83% | 1 | Jun 21, 2022 | |
| MCK McKesson | Maintains: Outperform | $325 → $361 | $543.30 | -33.55% | 2 | Apr 18, 2022 | |
| BTTX Better Therapeutics | Initiates: Outperform | n/a | $0.01 | - | 1 | Nov 10, 2021 | |
| OTRK Ontrak | Initiates: Outperform | n/a | $0.29 | - | 1 | Jul 16, 2020 | |
| PINC Premier | Initiates: Market Perform | n/a | $20.96 | - | 1 | Feb 13, 2018 | |
| MDRX Veradigm | Upgrades: Outperform | n/a | $7.96 | - | 1 | Sep 11, 2017 |
Teladoc Health
Apr 26, 2024
Maintains: Hold
Price Target: $16 → $15
Current: $13.01
Upside: +15.30%
ICON PLC
Apr 26, 2024
Maintains: Buy
Price Target: $343 → $349
Current: $308.31
Upside: +13.20%
GoodRx Holdings
Mar 1, 2024
Maintains: Outperform
Price Target: $12 → $14
Current: $7.19
Upside: +94.71%
Charles River Laboratories International
Sep 25, 2023
Maintains: Market Perform
Price Target: $212 → $209
Current: $229.03
Upside: -8.75%
Cardinal Health
Aug 16, 2023
Maintains: Market Perform
Price Target: $88 → $90
Current: $103.21
Upside: -12.80%
Talkspace
May 3, 2023
Maintains: Outperform
Price Target: $4 → $5
Current: $3.12
Upside: +60.26%
American Well
Mar 23, 2023
Downgrades: Market Perform
Price Target: $5 → $2.5
Current: $0.53
Upside: +373.48%
Veeva Systems
Mar 6, 2023
Maintains: Market Perform
Price Target: $184 → $189
Current: $200.91
Upside: -5.93%
IQVIA Holdings
Dec 6, 2022
Initiates: Outperform
Price Target: $251
Current: $234.88
Upside: +6.86%
Cue Health
Nov 14, 2022
Maintains: Outperform
Price Target: $9 → $7
Current: $0.14
Upside: +4,864.54%
Owlet
Oct 20, 2022
Maintains: Outperform
Price Target: $70 → $56
Current: $4.16
Upside: +1,246.15%
DarioHealth
Aug 16, 2022
Maintains: Outperform
Price Target: $18 → $14
Current: $1.48
Upside: +845.95%
Evolent Health
Jun 21, 2022
Maintains: Outperform
Price Target: $48 → $50
Current: $27.65
Upside: +80.83%
McKesson
Apr 18, 2022
Maintains: Outperform
Price Target: $325 → $361
Current: $543.30
Upside: -33.55%
Better Therapeutics
Nov 10, 2021
Initiates: Outperform
Price Target: n/a
Current: $0.01
Upside: -
Ontrak
Jul 16, 2020
Initiates: Outperform
Price Target: n/a
Current: $0.29
Upside: -
Premier
Feb 13, 2018
Initiates: Market Perform
Price Target: n/a
Current: $20.96
Upside: -
Veradigm
Sep 11, 2017
Upgrades: Outperform
Price Target: n/a
Current: $7.96
Upside: -